ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+49.1%/yr
vs -16.4%/yr prior
Acceleration
+65.4pp
Accelerating
Percentile
P72
Within normal range
vs 3Y Ago
3.3x
Strong expansion
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.83% |
| Q3 2025 | 29.00% |
| Q2 2025 | 33.33% |
| Q1 2025 | -87.50% |
| Q4 2024 | 33.33% |
| Q3 2024 | 40.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 50.00% |
| Q4 2023 | -110.53% |
| Q3 2023 | 40.63% |
| Q2 2023 | 8.57% |
| Q1 2023 | -29.63% |
| Q4 2022 | 3.57% |
| Q3 2022 | -16.67% |
| Q2 2022 | 7.69% |
| Q1 2022 | -13.04% |
| Q4 2021 | -4.55% |
| Q3 2021 | 4.35% |
| Q2 2021 | -9.52% |
| Q1 2021 | -16.67% |
| Q4 2020 | -5.88% |
| Q3 2020 | -30.77% |
| Q2 2020 | -34.44% |
| Q1 2020 | -44.11% |
| Q4 2019 | -69.44% |
| Q3 2019 | 6.38% |
| Q2 2019 | 23.09% |
| Q1 2019 | -3.19% |
| Q4 2018 | 28.55% |
| Q3 2018 | 14.84% |
| Q2 2018 | -0.69% |
| Q1 2018 | -12.26% |
| Q4 2017 | -2.79% |
| Q3 2017 | -4.72% |
| Q2 2017 | 3.49% |
| Q1 2017 | -1.08% |
| Q4 2016 | 24.00% |
| Q3 2016 | 2.90% |
| Q2 2016 | -6.50% |
| Q1 2016 | 60.88% |